Frequently searched keywords:
Haber tarihi: 30/01/2026
Last update date: 30.04.2026
HERDEM Çare TBL1XR1 Research and Support Association & ACURARE Collaboration Meeting was held at our university to discuss ongoing scientific studies in the field of rare diseases and current therapeutic approaches.
The meeting began with the opening presentation by Prof. Dr. Yasemin Alanay, Director of the University Rare Diseases and Orphan Drugs Research and Application Center (ACURARE).
The program was attended by Ayşegül Altınbaş, President of HERDEM Çare TBL1XR1 Research and Support Association, Vice President Berrin Zorlu, Board Member Nusret Altınbaş, and other association members.
Within the scope of the program, planned research in Turkey on TBL1XR1-related rare neurodevelopmental disorders was presented. The brain organoid development project was introduced by Assoc. Prof. Dr. Kaya Bilgüvar, Member of the ACURARE Executive Board and Head of the Department of Medical Genetics. The presentation highlighted the aim of contributing to the understanding of various neurological disorders such as autism and epilepsy.
Additionally, Assoc. Prof. Dr. Peter Ng presented “Gene Therapies in Rare Diseases,” addressing current scientific approaches and therapeutic perspectives. Multidisciplinary studies in the field of rare diseases, spanning from diagnosis to treatment and from research to clinical practice, were evaluated.